Cancer Research
Senolytics Fail to Protect Bone From Chemotherapy-Induced Loss
A mouse study finds that senolytic drugs cannot prevent chemotherapy-driven bone loss, challenging a leading hypothesis about its cause.
Research Paper
May 7, 2026 0
2 articles
A mouse study finds that senolytic drugs cannot prevent chemotherapy-driven bone loss, challenging a leading hypothesis about its cause.
Study reveals how common cancer drugs trigger dormant tumor cells to reactivate and spread, offering new prevention strategies.